Related Experiment Videos
The cost-effectiveness of cervical-vaginal rescreening
1Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, 52242-1009, USA.
American Journal of Clinical Pathology
|November 14, 1997
Summary
Manual rescreening of cervical-vaginal smears offers minimal life expectancy gains. Full rescreening is more cost-effective than no rescreening if costs are low, suggesting limited utility for 10% strategies.
Area of Science:
- Gynecologic pathology
- Health economics
- Diagnostic test evaluation
Background:
- Current laboratory practices often include 10% manual rescreening of cervical-vaginal smears.
- The cost-effectiveness of various rescreening strategies, including 10% manual rescreening, is not well-established.